817 AST-201 (pUMVC3-hIGFBP2 N-terminus) demonstrates anti-tumor effect in an ovarian cancer mouse model
Main Authors: | Mary L Disis, Eunkyo Joung, Jinback Lim, Hyo-Hyun Park, Hun Jung, Jinho Kang, Jin Kyeong Choi, Jee Hyun Choi, Seong-Yong Jang, Min-Ah Kim, Myeong-Kyu Park |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Humoral immune responses in mice immunized with region of difference DNA vaccine constructs of pUMVC6 and pUMVC7
by: Shumaila N. M. Hanif, et al.
Published: (2017-01-01) -
1422 Th1-specific TROP2 vaccine (AST-07X) elicits strong antigen-specific T cell responses in vitro
by: Eunkyo Joung, et al.
Published: (2023-11-01) -
897 AST-301, a pDNA-based cancer vaccine encoding HER2-ICD, enhances anti-tumor effect of HER2-ADC in a HER2-expressed gastric cancer xenograft model
by: Eunkyo Joung, et al.
Published: (2023-11-01) -
1421 Th1-specific epitope selection for an off-the-shelf type KRAS cancer vaccine: epitopes of non-mutated lesion
by: Eunkyo Joung, et al.
Published: (2023-11-01) -
1414 Antitumor effect of HER2-hICD vaccine combining with HER2 ADC depending on T cell existence in a mouse model: pooled analysis
by: Hye-Ran Kim, et al.
Published: (2023-11-01)